During the past decade, Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital" #1 sponsor was "SWOG Cancer Research Network" with 13 trials, followed by "NSABP Foundation Inc" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Children's Oncology Group" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital" are "Breast Cancer" (9 trials), "Colorectal Cancer" (3 trials), "Melanoma (Skin)" (3 trials), "Metastatic Cancer" (2 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital" are "Drug" (22 trials), "Biological" (8 trials), "Procedure" (5 trials), "Other" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "cisplatin" (4 trials), "bevacizumab" (3 trials), "docetaxel" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital" are 17 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".